Royal Bank of Canada’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$79K Buy
26,064
+22,564
+645% +$68.4K ﹤0.01% 5378
2025
Q1
$15K Hold
3,500
﹤0.01% 5644
2024
Q4
$18K Hold
3,500
﹤0.01% 5660
2024
Q3
$6K Sell
3,500
-2,802
-44% -$4.8K ﹤0.01% 6000
2024
Q2
$13K Buy
6,302
+2,316
+58% +$4.78K ﹤0.01% 5861
2024
Q1
$16K Buy
3,986
+3,258
+448% +$13.1K ﹤0.01% 5572
2023
Q4
$1K Buy
728
+228
+46% +$313 ﹤0.01% 6440
2023
Q3
$1K Sell
500
-2,920
-85% -$5.84K ﹤0.01% 6438
2023
Q2
$8K Buy
3,420
+3,320
+3,320% +$7.77K ﹤0.01% 6095
2023
Q1
$0 Hold
100
﹤0.01% 6928
2022
Q4
$0 Hold
100
﹤0.01% 7143
2022
Q3
$0 Hold
100
﹤0.01% 7274
2022
Q2
$0 Sell
100
-46
-32% ﹤0.01% 7129
2022
Q1
$1K Sell
146
-13
-8% -$89 ﹤0.01% 7132
2021
Q4
$1K Sell
159
-505
-76% -$3.18K ﹤0.01% 6996
2021
Q3
$4K Sell
664
-290
-30% -$1.75K ﹤0.01% 6680
2021
Q2
$9K Sell
954
-15
-2% -$142 ﹤0.01% 6411
2021
Q1
$15K Buy
969
+369
+62% +$5.71K ﹤0.01% 6104
2020
Q4
$15K Sell
600
-157
-21% -$3.93K ﹤0.01% 5653
2020
Q3
$13K Buy
757
+157
+26% +$2.7K ﹤0.01% 5366
2020
Q2
$18K Hold
600
﹤0.01% 5162
2020
Q1
$14K Buy
+600
New +$14K ﹤0.01% 5207
2019
Q1
Sell
-110
Closed -$10K 5925
2018
Q4
$10K Buy
110
+14
+15% +$1.27K ﹤0.01% 5115
2018
Q3
$7K Hold
96
﹤0.01% 5513
2018
Q2
$9K Hold
96
﹤0.01% 5276
2018
Q1
$10K Hold
96
﹤0.01% 5115
2017
Q4
$7K Buy
96
+12
+14% +$875 ﹤0.01% 5236
2017
Q3
$7K Sell
84
-65
-44% -$5.42K ﹤0.01% 5603
2017
Q2
$9K Sell
149
-71
-32% -$4.29K ﹤0.01% 5098
2017
Q1
$15K Sell
220
-82
-27% -$5.59K ﹤0.01% 5095
2016
Q4
$23K Buy
302
+286
+1,788% +$21.8K ﹤0.01% 4940
2016
Q3
$6K Buy
+16
New +$6K ﹤0.01% 5162
2015
Q4
Sell
-19
Closed -$11K 5985
2015
Q3
$11K Buy
19
+7
+58% +$4.05K ﹤0.01% 5256
2015
Q2
$8K Buy
+12
New +$8K ﹤0.01% 5633